Skip to main content
. 2018 Oct 24;23(1):340–348. doi: 10.1111/jcmm.13935

Figure 4.

Figure 4

Combination of CUDC‐907 with other specific inhibitors show synergistic effects. A, Percentage of cell death, as measured by PI staining, in MEC‐1 cells treated with different concentrations of CUDC‐907 for 48 h, alone or in combination with IMD‐0354, ibrutinib or ABT‐199. Graphs show average of three independent experiments. B, Same in CLL patient cells cultured in the presence of 10 ng/mL IL‐4 and CD154 for 24 h before treated with drug combinations